Sub-chronic administration of LY294002 sensitizes cervical cancer cells to chemotherapy by enhancing mitochondrial JNK signaling Article

Chambers, Tara P, Portalatin, Gilda M, Paudel, Iru et al. (2015). Sub-chronic administration of LY294002 sensitizes cervical cancer cells to chemotherapy by enhancing mitochondrial JNK signaling . BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 463(4), 538-544. 10.1016/j.bbrc.2015.05.075

cited authors

  • Chambers, Tara P; Portalatin, Gilda M; Paudel, Iru; Robbins, Charles J; Chambers, Jeremy W

sustainable development goals

authors

publication date

  • August 7, 2015

webpage

published in

keywords

  • ACTIVATION
  • BREAST-CANCER
  • Biochemistry & Molecular Biology
  • Biophysics
  • CHEMOSENSITIZATION
  • Chemo-sensitization
  • DEATH
  • IN-VITRO
  • JNK
  • LIVER-INJURY
  • LY294002
  • Life Sciences & Biomedicine
  • Mitochondria
  • PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
  • PI3K
  • PROTEIN
  • SAB SH3BP5
  • Sab
  • Science & Technology
  • TERMINAL KINASE JNK

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 538

end page

  • 544

volume

  • 463

issue

  • 4